Personal Finance

Eisai Q3 FY2025 slides reveal 109% growth in LEQEMBI sales, strategic oncology investments

By administraciónFebruary 9, 2026No Comments1 Min Read

Eisai Q3 FY2025 slides reveal 109% growth in LEQEMBI sales, strategic oncology investments

Eisai FY2025 growth Investments LEQEMBI oncology reveal sales slides Strategic

Previous ArticleWhen a Side Business Actually Makes Sense for Doctors

Next Article How ETFs, Open End Mutual Funds, and Closed End Funds Trade

administración

Leave A Reply